Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery

Fangqiong Tang,Linlin Li,Dong Chen

DOI: https://doi.org/10.1002/adma.201104763

IF: 29.4

2012-02-29

Advanced Materials

Abstract:In the past decade, mesoporous silica nanoparticles (MSNs) have attracted more and more attention for their potential biomedical applications. With their tailored mesoporous structure and high surface area, MSNs as drug delivery systems (DDSs) show significant advantages over traditional drug nanocarriers. In this review, we overview the recent progress in the synthesis of MSNs for drug delivery applications. First, we provide an overview of synthesis strategies for fabricating ordered MSNs and hollow/rattle-type MSNs. Then, the in vitro and in vivo biocompatibility and biotranslocation of MSNs are discussed in relation to their chemophysical properties including particle size, surface properties, shape, and structure. The review also highlights the significant achievements in drug delivery using mesoporous silica nanoparticles and their multifunctional counterparts as drug carriers. In particular, the biological barriers for nano-based targeted cancer therapy and MSN-based targeting strategies are discussed. We conclude with our personal perspectives on the directions in which future work in this field might be focused.

materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to develop and optimize the performance of mesoporous silica nanoparticles (MSNs) as a drug delivery system in order to overcome the limitations of existing nanopreparations in clinical applications. Specifically, the paper focuses on the following aspects:

1. **Synthesis control**: Research on how to precisely control the size, morphology, pore size and pore structure of MSNs through different synthesis strategies (such as the synthesis methods of ordered MSNs and hollow/ring - type MSNs), thereby improving their performance as drug carriers.

2. **Biocompatibility and biotransportability**: Explore the biocompatibility of MSNs and their migration characteristics in vivo, especially how these characteristics are affected by the physicochemical properties of the particles (such as particle size, surface properties, shape and structure).

3. **Drug delivery**: Summarize the progress in the field of drug delivery using MSNs and their multifunctional composites in recent years, especially their applications in cancer treatment. Discuss how MSNs can overcome the deficiencies of traditional drug delivery systems in terms of drug - loading capacity, targeted delivery and release mechanisms.

4. **Biological barriers and targeting strategies**: Analyze the biological barriers in nanotechnology - based targeted cancer treatment and propose targeting strategies using MSNs.

By reviewing the latest progress in these aspects, the paper aims to provide directions for future research and promote the application of MSNs in the biomedical field, especially in clinical translation.